{
    "clinical_study": {
        "@rank": "166520", 
        "arm_group": [
            {
                "arm_group_label": "Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "Intraoperative continuous IV infusion of Lidocaine at 2mg/kg/hr"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Intraoperative continuous placebo infusion of dextrose at 2mg/kg/hr"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective is to assess the feasibility and safety of administering continuous\n      intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y\n      Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration\n      versus placebo (dextrose administration) (initiated at the time of anesthesia induction and\n      continued until extubation) will reduce postoperative narcotic requirements."
        }, 
        "brief_title": "Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients", 
        "condition": "Bariatric Surgical Pain", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients between the ages of 18-65 years old\n\n          -  BMI \u2265 40 kg/m2, \u2264 60 kg/m2\n\n          -  Undergoing a primary laparoscopic RYGB by Dr. Murr\n\n          -  Agree to be followed 24 hours postoperatively\n\n          -  Normal K+ and Mg++ serum levels\n\n        Exclusion Criteria:\n\n          -  BMI less than 40 kg/m2, > 60 kg/m2\n\n          -  Laparoscopic RYGB surgery performed by a surgeon other than Dr. Murr\n\n          -  Allergy to lidocaine\n\n          -  Allergy to hydromorphone or ketorolac\n\n          -  Allergy to corn or amide anesthetics\n\n          -  Use of (thioridizine)\n\n          -  Pregnancy\n\n          -  Abnormalities of ALT or AST\n\n          -  Intra-operative diagnosis of cirrhosis or portal hypertension\n\n          -  Intraoperative complications per surgeon\n\n          -  Intraoperative extensive adhesions per surgeon\n\n          -  Chronic pain syndrome and chronic use of narcotics\n\n          -  Severe back pain secondary to degenerative joint disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01944098", 
            "org_study_id": "Pro00002417"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lidocaine", 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "contact": {
                "email": "rkarlnoski@fgtba.com", 
                "last_name": "Rachel Karlnoski, PhD", 
                "phone": "813-844-4413"
            }, 
            "facility": {
                "address": {
                    "city": "Tampa", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33606"
                }, 
                "name": "Tampa General Hospital"
            }, 
            "investigator": {
                "last_name": "Enrico Camporesi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Systemic Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients: A Randomized, Placebo-Controlled Pilot Study", 
        "overall_contact": {
            "email": "rkarlnoski@fgtba.com", 
            "last_name": "Rachel Karlnoski, PhD", 
            "phone": "813.844.4413"
        }, 
        "overall_official": {
            "affiliation": "Florida Gulf-to-Bay Anesthesiology", 
            "last_name": "Rachel Karlnoski, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting", 
                "measure": "Postoperative pain", 
                "safety_issue": "Yes", 
                "time_frame": "6 hours post-surgery"
            }, 
            {
                "description": "Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting", 
                "measure": "Postoperative Pain", 
                "safety_issue": "Yes", 
                "time_frame": "12 hours post-surgery"
            }, 
            {
                "description": "Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting", 
                "measure": "Postoperative Pain", 
                "safety_issue": "Yes", 
                "time_frame": "18 hours post-surgery"
            }, 
            {
                "description": "Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting", 
                "measure": "Postoperative Pain", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours post-surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01944098"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of South Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of South Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}